HSG

Henry Schein Announces Appointment of Three New Members to the Company’s Executive Management Committee

Retrieved on: 
星期三, 四月 10, 2024
Medical Supplies, Surgery, General Health, Health, Medical Devices, Hospitals, Dental, Other Health, KPMG, Software, Elective surgery, HSG, Acquisition, Multimedia, EMC, Management

HSG includes a range of company-owned manufacturing brands in the high-growth endodontic, orthodontic, and orthopedic markets.

Key Points: 
  • HSG includes a range of company-owned manufacturing brands in the high-growth endodontic, orthodontic, and orthopedic markets.
  • “We are delighted to welcome three strong and proven leaders to the Henry Schein Executive Management Committee,” said Stanley Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc. “Steve, Bianka, and Tom have each demonstrated vision and commitment in inspiring and leading our teams to excellence in a quickly changing global healthcare marketplace.
  • Ms. Wilson joined Henry Schein in 2018 after a successful 25-year career in finance and consulting.
  • Mr. Popeck joined Henry Schein in 2019 with more than 20 years of sales leadership and general management experience, including extensive experience in the medical device sector.

Former Supreme Court Clerk Jack Millman Rejoins Holwell Shuster & Goldberg

Retrieved on: 
星期二, 三月 5, 2024
Legal, Professional Services, Private practice, Court, Antonin Scalia, Multimedia, Supreme, ADR, University School, District court, ExxonMobil, Justice Thomas, Levy, Appellate Division, Bronze Star Medal, Lawyer, HSG, Supreme court, Justice

Holwell Shuster & Goldberg LLP announced today that Jack Millman , a former associate at the firm and former law clerk to Supreme Court Justice Clarence Thomas, has rejoined HSG.

Key Points: 
  • Holwell Shuster & Goldberg LLP announced today that Jack Millman , a former associate at the firm and former law clerk to Supreme Court Justice Clarence Thomas, has rejoined HSG.
  • Jack joins three other HSG lawyers who previously clerked at the Supreme Court: Gregory Dubinsky , Vincent Levy , and Daniel Sullivan .
  • View the full release here: https://www.businesswire.com/news/home/20240305490449/en/
    Former Supreme Court Clerk Jack Millman Rejoins Holwell Shuster & Goldberg (Photo: Business Wire)
    “Jack is a widely recognized talent who further deepens our roster of appellate advocates with experience at the highest levels of the judicial system,” said Richard Holwell , co-founder of HSG and former judge in the U.S. District Court for the Southern District of New York.
  • We are delighted to welcome him back.”
    Jack clerked on the Supreme Court during the 2020-21 term, Justice Thomas’ 30th on the Court.

Boston IVF Welcomes Dr. Meaghan Delaney to its Springfield Fertility Center, Expanding Access to Expert Care in Western Massachusetts

Retrieved on: 
星期二, 二月 20, 2024
Boston University, Texas Children's Hospital, IUI, Hysterosalpingography, Medicine, MD, Telehealth, Semen analysis, IVF, Fertility, PCOS, REI, Patient, Pioneer Valley, Family, Medical Center, HSG, Birth control

SPRINGFIELD, Mass., Feb. 20, 2024 /PRNewswire-PRWeb/ -- Boston IVF, one of the world's most experienced fertility treatment providers, which has assisted in over 150,000 babies born since 1986, is pleased to announce the addition of reproductive endocrinologist, Dr. Meaghan Delaney, MD to its new fertility center in Springfield, MA.

Key Points: 
  • The addition of Dr. Meaghan Delaney to Boston IVF and its fertility clinic in Springfield enhances the accessibility of prompt reproductive care for those desiring to build a family.
  • "Dr. Delaney's return to western Massachusetts and commitment to patient well-being ensure seamless care, delivering invaluable advantages to our patients," stated David Stern, CEO of Boston IVF.
  • Dr. Delaney transitions to Boston IVF from her position as the Medical Director at the UMass Memorial Fertility Center in Worcester, MA.
  • "Dr. Delaney's return to western Massachusetts and commitment to patient well-being ensure seamless care, delivering invaluable advantages to our patients," stated David Stern, CEO of Boston IVF.

SoftwareOne Founding Shareholders request the convening of an EGM

Retrieved on: 
星期一, 二月 5, 2024
Sika AG, Microware, Skin, Corporation, Peat, Applied science, HSG, Ringier, Financial management, Hallenstadion, Civil Service (United Kingdom), CPA, Forbo Holding AG, Compensated emancipation, McKinsey & Company, University, Information technology, Business, European Business School, Actium, Dr. Oetker, Oestrich-Winkel, Supervisory board, CFO, GAAP, Sika, Audit committee, Nomination, New Vision Group, Management

In addition, Annabella Bassler restructured Ringier’s operations in Romania into a profitable and modern media company from mid-2014 until 2021.

Key Points: 
  • In addition, Annabella Bassler restructured Ringier’s operations in Romania into a profitable and modern media company from mid-2014 until 2021.
  • Before joining Ringier, she worked at the finance department of Hamburg Süd, the shipping company of the Oetker Group, from 2004 to 2007.
  • Annabella Bassler studied Economics at the European Business School in Oestrich-Winkel, Buenos Aires and Los Angeles, where she also received her doctorate.
  • Additionally, he was a member of the Board of Directors at SoftwareOne until 2022.

Holwell Shuster & Goldberg Promotes Daniel M. Horowitz to Partner

Retrieved on: 
星期一, 一月 8, 2024
Legal, Professional Services, Goldberg, Partnership, HSG, Multimedia, Divorce, Justice, Visa, Daniel, Cornell Law School, Insurance, Election Commission, Every Voice, District court

Holwell Shuster & Goldberg, one of the premier litigation boutiques in the country, has promoted Daniel M. Horowitz to partner, effective January 1, 2024.

Key Points: 
  • Holwell Shuster & Goldberg, one of the premier litigation boutiques in the country, has promoted Daniel M. Horowitz to partner, effective January 1, 2024.
  • Daniel has spent his entire private practice career at HSG, having risen through the ranks since joining the firm as a junior associate in 2016 immediately following his clerkships.
  • View the full release here: https://www.businesswire.com/news/home/20240108002902/en/
    Holwell Shuster & Goldberg Promotes Daniel M. Horowitz to Partner (Photo: Business Wire)
    “We’re privileged to have a litigator of Daniel’s character and talent at our firm, and now among our partnership,” said Richard Holwell , co-founding partner of the firm and former judge in the U.S. District Court for the Southern District of New York.
  • Daniel plays a leading role in the firm’s representation of Chubb against various players in the pharmaceutical industry in insurance coverage litigation arising from the opioid crisis.

Isao Kobayashi Assumes President and CEO Role at Canon U.S.A., Inc.

Retrieved on: 
星期四, 一月 4, 2024
Management, HSG, Imaging, Canon Inc., COVID-19, Senior

Mr. Kobayashi began his career with Canon Inc. in 1990 in the photocopier sales division and progressed to Assistant Manager in the Canon U.S.A. inkjet printer group in 2005.

Key Points: 
  • Mr. Kobayashi began his career with Canon Inc. in 1990 in the photocopier sales division and progressed to Assistant Manager in the Canon U.S.A. inkjet printer group in 2005.
  • In April 2022, Mr. Kobayashi was promoted to Senior Vice President and General Manager of Canon U.S.A. and was appointed as an Executive Officer of Canon Inc., a title he still holds today.
  • In January 2023, Mr. Kobayashi was named President and CEO of Canon Canada, where he served for one year.
  • Akira Ikeda will serve as President and CEO of Canon Mexicana and Canon Panama after his role as Vice President of Canon Mexicana.

EQS-News: Vossloh expands cooperation with Deutsche Bahn

Retrieved on: 
星期三, 十二月 13, 2023
HSG, Vossloh, Federal Executive Boards, Deutsche Bahn, High Speed, Rail transport

By signing a four-year framework agreement with Deutsche Bahn in the Customized Modules division, Vossloh is further expanding its market position in Germany.

Key Points: 
  • By signing a four-year framework agreement with Deutsche Bahn in the Customized Modules division, Vossloh is further expanding its market position in Germany.
  • Over the next four years, Vossloh will supply a total of at least 600 switches to Deutsche Bahn.
  • Deutsche Bahn is currently renewing its rail network as part of a comprehensive modernization program and is building more than ever before.
  • A few days ago, Vossloh and Deutsche Bahn jointly organized an "Innovation Day" at Vossloh AG's headquarters in Werdohl with the aim of exchanging ideas and further intensifying cooperation.

Teva to Present New Data Supporting Safety, Efficacy and Real-World Effectiveness of AUSTEDO® (deutetrabenazine) Tablets at the 2023 HSG Annual Meeting

Retrieved on: 
星期四, 十一月 2, 2023
Health, Neurology, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, FDA, VMAT2, NNH, NYSE, Georgetown University School of Medicine, Medication, HD, MD, NNT, Psychiatry, START, Doctor of Philosophy, PGIC, TEVA, Yahoo Beijing Global R&D Center, Teva, Tetrabenazine, Interim, Annual general meeting, Teva Pharmaceuticals, TASE, TMC, Education, Safety, HSG, Patient, Pharmaceutical industry

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new HD data will be presented at the Huntington Study Group® (HSG) Annual Meeting on November 2-4 in Phoenix, AZ.

Key Points: 
  • Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new HD data will be presented at the Huntington Study Group® (HSG) Annual Meeting on November 2-4 in Phoenix, AZ.
  • TMC scores mostly improved with AUSTEDO treatment, and the safety profile was consistent with AUSTEDO’s known safety profile.
  • NNTs for treatment success based on CGIC and PGIC ranged from 3-4 and 4-5, respectively, for the VMAT2 inhibitors.
  • Significant NNHs included:
    Together, the data provide additional insight into the real-world efficacy and safety of AUSTEDO for patients with HD chorea.

Neurocrine Biosciences® Presents INGREZZA® (valbenazine) Capsules Interim Data Demonstrating Sustained Improvements in Chorea Associated With Huntington's Disease Through Week 50 at Huntington Study Group 2023

Retrieved on: 
星期四, 十一月 2, 2023
Week, Falls, Food, Fatigue, HD, Treatment, Neurocrine, Disease, Neurocrine Biosciences, Maintenance, Journal, Somnolence, Poster, Abstract, Huntington's disease, Interim, Capsule, George Huntington, HSG, Food and Drug Administration, SAN, Dietary supplement, Pharmaceutical industry, Chorea

Interim data suggest one-capsule, once-daily INGREZZA improved chorea at the first evaluation at Week 2 with sustained efficacy through Week 50.

Key Points: 
  • Interim data suggest one-capsule, once-daily INGREZZA improved chorea at the first evaluation at Week 2 with sustained efficacy through Week 50.
  • These data will be presented at the 30th Annual Meeting of the Huntington Study Group on November 2–4 in Phoenix.
  • "These interim data provide insight on the clinically meaningful and sustained improvements participants are experiencing with INGREZZA for the treatment of chorea," said Eiry W. Roberts, M.D., Chief Medical Officer at Neurocrine Biosciences®.
  • Additional HD chorea presentations at the 30th Annual Meeting of the HSG include:
    The full abstracts can be accessed on the Journal of Huntington's Disease website.

ImmunOs Therapeutics Appoints Dr. Constanze Guenther as Senior Vice President, CMC and Technical Development

Retrieved on: 
星期二, 九月 19, 2023
Process, Change, University, Therapy, Senior, CMC, Cancer, Immuno AG, MBA, Research, University residence hall network, Doctor of Philosophy, HSG, Molecular Partners, Novartis, Biology, FDA, Technical, Inflammation, Pharmaceutical industry, Vaccine, Tisagenlecleucel, MD

In this role, she headed a team of technical project leads responsible for all CMC aspects of these programs.

Key Points: 
  • In this role, she headed a team of technical project leads responsible for all CMC aspects of these programs.
  • We are excited to have her join the team and lead our CMC and technical development efforts to develop and manufacture novel protein- and antibody-based therapies," said Steve Coats, PhD, Chief Development Officer at ImmunOs.
  • Her breadth and depth of expertise in technical development, manufacturing and operations will be important for advancing our first-in-class pipeline of multi-functional immunotherapies to and through clinical development."
  • "I believe that ImmunOs´ expertise in pioneering HLA-based therapeutics focusing on both oncology and immunology, led by IOS-1002, ImmunOs´ lead clinical candidate in oncology, is at the forefront of current research," said Dr. Constanze Guenther, Senior Vice President, CMC and Technical Development at ImmunOs.